Back to RTW INVESTMENTS, LP RTW INVESTMENTS, LP

SYRESYRE
11 quarters

Position history for RTW INVESTMENTS, LPRTW INVESTMENTS, LP's holdings in Spyre Therapeutics, Inc

RTW INVESTMENTS, LP holds 4.3M shares of SYRE (Spyre Therapeutics, Inc), worth $377.5M as of 2026-Q2. The position was increased (+1.9% shares). SYRE represents 3.2% of RTW INVESTMENTS, LP's portfolio.

Current Value

$377.5M

Current Shares

4.3M

Total Value Change

+$329.4M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+1.9%
$377.5M3.2%$88.78
58
2026-Q1
Unchanged
4.2M
0.0%
$210.4M2.1%$40.07
0
2025-Q4
Increased
4.2M
+15.2%
$136.7M1.4%$31.88
55
2025-Q3
Unchanged
3.6M
0.0%
$60.7M0.7%$16.36
0
2025-Q2
Unchanged
3.6M
0.0%
$54.2M0.8%$15.22
0
2025-Q1
Unchanged
3.6M
0.0%
$58.4M0.9%$17.94
0
2024-Q4
Increased
3.6M
+11.2%
$84.3M1.3%$22.54
52
2024-Q3
Unchanged
3.3M
0.0%
$95.8M1.4%$28.49
0
2024-Q2
Increased
3.3M
+45.9%
$76.6M1.2%$23.51
64
2024-Q1
Unchanged
2.2M
0.0%
$84.7M1.3%$37.93
0
2023-Q4
New
2.2M
-
$48M0.8%$21.52
57

Other major holders of SYRE: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used